Detalhe da pesquisa
1.
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
Transplant Cell Ther
; 27(4): 311.e1-311.e10, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33836871
2.
Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain.
BMJ Case Rep
; 13(10)2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051199